NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |